Patents by Inventor Hiroyuki Ueno

Hiroyuki Ueno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220233665
    Abstract: The present invention provides a medicinal composition containing a T cell population that exhibits an excellent antigen specificity and has genetic diversity, and a method for preventing or treating cancer using the medicinal composition.
    Type: Application
    Filed: June 12, 2020
    Publication date: July 28, 2022
    Inventors: Yutaka Yasui, Yasumichi Hitoshi, Hiroyuki Ueno, Shin Kaneko
  • Publication number: 20220226291
    Abstract: This invention provides a method for enhancing antitumor effects of a ribonucleotide reductase (RNR) inhibitory compound. A pharmaceutical composition for treating and/or preventing a tumor used in combination with an immune checkpoint molecule regulator comprising a sulfonamide compound represented by Formula (I) or a salt thereof is also provided.
    Type: Application
    Filed: May 28, 2020
    Publication date: July 21, 2022
    Applicant: Taiho Pharmaceutical Co., Ltd.
    Inventors: Hiroyuki Ueno, Sayaka Tsukioka
  • Patent number: 11154432
    Abstract: Disposable pull-on diapers of the present disclosure may have optimized waist circumferential length and leg opening length.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: October 26, 2021
    Assignee: The Procter & Gamble Company
    Inventors: Koichi Morimoto, Takashi Umeo, Hiroyuki Ueno, Katsuhiro Yonemura
  • Publication number: 20210260833
    Abstract: There is provided an adhesive application apparatus capable of efficiently applying an adhesive without inhibiting curing of the adhesive. An adhesive application apparatus of the present invention includes a mounting table 10, an adhesive dosing unit 20, and an ultraviolet irradiation unit 30, and it applies a delayed-ultraviolet-curable adhesive 200 to a surface of a panel 100. The panel 100 is mounted on a mounting surface S10 of the mounting table 10. The adhesive dosing unit 20 applies the adhesive 200 to the surface of the panel 100 mounted on the mounting table 10 by discharging the adhesive 200 from an adhesive dosing port H20. The ultraviolet irradiation unit 30 irradiates the adhesive 200 dosed from the adhesive dosing port H20 with ultraviolet light L. Here, the ultraviolet irradiation unit 30 irradiates the adhesive 200 with the ultraviolet light L along the mounting surface S10 before the adhesive 200 dosed from the adhesive dosing port H20 is applied to the surface of the panel 100.
    Type: Application
    Filed: May 12, 2021
    Publication date: August 26, 2021
    Applicant: MOMENTIVE PERFORMANCE MATERIALS JAPAN LLC
    Inventors: Makoto SAKAKIBARA, Hiroyuki UENO
  • Publication number: 20210238550
    Abstract: The present invention provides a method for producing a regenerated T cell population via iPS cells, wherein the said regenerated T cell population maintains the repertoire diversity of a T cell population before initialization and has specificity to an antigen. The method comprises steps of (1) bringing a T cell population into contact with one or more tumor-related antigens, or a biological tissue containing one or more tumor-related antigens, or a crushed material or a lysate thereof, and enriching the T cell population having specificity to the tumor-related antigens, (2) initializing the enriched T cell population to iPS cells, and culturing while maintaining the repertoire diversity of the enriched T cell population, and (3) producing a regenerated T cell population from the cultured iPS cells.
    Type: Application
    Filed: July 30, 2019
    Publication date: August 5, 2021
    Inventors: Yutaka Yasui, Yasumichi Hitoshi, Hiroyuki Ueno, Yoshimoto Katsura, Shin Kaneko
  • Patent number: 10889555
    Abstract: The present invention provides a novel sulfonamide compound having a ribonucleotide reductase inhibitory activity or a salt thereof, and a pharmaceutical composition containing the same as an active ingredient. A compound represented by Formula (I) [wherein, X1 represents an oxygen atom or the like; X2 represents an oxygen atom; X3 represents —NH—; X4 represents a hydrogen atom or the like; R1 represents —C(R11)(R12)— or the like; R11 and R12 are the same or different and each represents a hydrogen atom or the like; R2 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R3 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R4 represents a hydrogen atom or the like] or a salt thereof.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: January 12, 2021
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Seiji Miyahara, Hiroyuki Ueno, Shoki Hara, Yoshio Ogino
  • Publication number: 20200405697
    Abstract: The present invention provides a method of enhancing an antitumor effect by a compound strongly inhibiting ribonucleotide reductase (RNR) or a salt thereof. A combination formulation involving combined administration of a sulfonamide compound represented by Formula (I) [In the formula, X1 represents an oxygen atom or the like; X2 represents an oxygen atom; X3 represents —NH—; X4 represents a hydrogen atom or the like; R1 represents —C(R11) (R12)— or the like; R11 and R12 are the same or different and each represents a hydrogen atom or the like; R2 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R3 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R4 represents a hydrogen atom or the like] or a salt thereof, having RNR inhibitory activity, and other antitumor agent(s).
    Type: Application
    Filed: November 28, 2018
    Publication date: December 31, 2020
    Applicant: Taiho Pharmaceutical Co., Ltd.
    Inventors: Hiroyuki Ueno, Takuya Hoshino
  • Publication number: 20200399235
    Abstract: The present invention provides a novel sulfonamide compound having a ribonucleotide reductase inhibitory activity or a salt thereof, and a pharmaceutical composition containing the same as an active ingredient. A compound represented by Formula (I) [wherein, X1 represents an oxygen atom or the like; X2 represents an oxygen atom; X3 represents —NH—; X4 represents a hydrogen atom or the like; R1 represents —C(R11)(R12)— or the like; R11 and R12 are the same or different and each represents a hydrogen atom or the like; R2 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R3 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R4 represents a hydrogen atom or the like] or a salt thereof.
    Type: Application
    Filed: August 24, 2020
    Publication date: December 24, 2020
    Applicant: Taiho Pharmaceutical Co., Ltd.
    Inventors: Seiji Miyahara, Hiroyuki Ueno, Shoki Hara, Yoshio Ogino
  • Publication number: 20200345789
    Abstract: [Problem] To provide a method for producing a population of genetically diverse regenerated T cells via iPS cells, and to provide said population of regenerated T cells. [Solution] A method for producing a population of genetically diverse regenerated T cells via iPS cells, including: (1) obtaining a population of T cells that can recognize a target tissue or antigens from a population of the genetically diverse T cells; (2) reprogramming the obtained the population of T cells into iPS cells, culturing the iPS cells while maintaining genetic diversity; and (3) producing a population of the genetically diverse regenerated T cells from the iPS cells.
    Type: Application
    Filed: October 4, 2018
    Publication date: November 5, 2020
    Inventors: Yutaka Yasui, Yoshimoto Katsura, Hiroyuki Ueno, Shin Kaneko
  • Publication number: 20200157066
    Abstract: The present invention provides a novel sulfonamide compound having a ribonucleotide reductase inhibitory activity or a salt thereof, and a pharmaceutical composition containing the same as an active ingredient. A compound represented by Formula (I) [wherein, X1 represents an oxygen atom or the like; X2 represents an oxygen atom; X3 represents —NH—; X4 represents a hydrogen atom or the like; R1 represents —C(R11)(R12)— or the like; R11 and R12 are the same or different and each represents a hydrogen atom or the like; R2 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R3 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R4 represents a hydrogen atom or the like] or a salt thereof.
    Type: Application
    Filed: January 24, 2020
    Publication date: May 21, 2020
    Applicant: Taiho Pharmaceutical Co., Ltd.
    Inventors: Seiji Miyahara, Hiroyuki Ueno, Shoki Hara, Yoshio Ogino
  • Patent number: 10414153
    Abstract: Force for biasing a roller member is changed according to the contact state of first and second plate-like bodies during the travel of the roller member. By that, the pressing force per unit area given from the second plate-like body to the first plate-like body during travel is suppressed. An object to be transferred is satisfactorily transferred despite a change in the contact state of the plate-like bodies during the travel of the roller member.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: September 17, 2019
    Assignee: SCREEN Holdings Co., Ltd.
    Inventors: Itsuki Kajino, Mikio Masuichi, Hiroyuki Ueno, Kazuhiro Shoji
  • Publication number: 20190192356
    Abstract: Disposable pull-on diapers of the present disclosure may have optimized waist circumferential length and leg opening length.
    Type: Application
    Filed: March 6, 2019
    Publication date: June 27, 2019
    Inventors: Koichi Morimoto, Takashi Umeo, Hiroyuki Ueno, Katsuhiro Yonemura
  • Patent number: 10265221
    Abstract: Disposable pull-on diapers of the present disclosure may have optimized waist circumferential length and leg opening length.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: April 23, 2019
    Assignee: The Procter & Gamble Company
    Inventors: Koichi Morimoto, Takashi Umeo, Hiroyuki Ueno, Katsuhiro Yonemura
  • Publication number: 20180071771
    Abstract: A first movable body is provided movably in a separation direction and a first engaging member is provided for each suction unit. When the first movable body is moved in the separation direction, the plurality of first engaging members are respectively engaged with the first movable body in the same sequence as an array sequence of the suction units. Thereafter, the suction units are moved in the separation direction together with the first movable body.
    Type: Application
    Filed: August 14, 2017
    Publication date: March 15, 2018
    Inventors: Itsuki KAJINO, Miyoshi UENO, Mikio MASUICHI, Hiroyuki UENO, Kazuhiro SHOJI
  • Publication number: 20180029353
    Abstract: Force for biasing a roller member is changed according to the contact state of first and second plate-like bodies during the travel of the roller member. By that, the pressing force per unit area given from the second plate-like body to the first plate-like body during travel is suppressed. An object to be transferred is satisfactorily transferred despite a change in the contact state of the plate-like bodies during the travel of the roller member.
    Type: Application
    Filed: July 20, 2017
    Publication date: February 1, 2018
    Inventors: Itsuki KAJINO, Mikio MASUICHI, Hiroyuki UENO, Kazuhiro SHOJI
  • Publication number: 20180019644
    Abstract: An embodiment of the present invention stably eliminates high-frequency electromagnetic noise in a servo motor. A gear structure (10) includes: a first metal gear (1); a second metal gear (2); a first metal member (second housing 4b, motor bearing section 4c) electrically continuous with the first metal gear (1); a second metal member (shaft part 2a) electrically continuous with the second metal gear (2); and an electrical connector (conductive gasket 9) electrically connecting the first metal member and the second metal member to each other.
    Type: Application
    Filed: December 10, 2015
    Publication date: January 18, 2018
    Inventors: Kazushi OKADA, Hiroyuki UENO, Tai MIYAGAWA
  • Publication number: 20170135868
    Abstract: Disposable pull-on diapers of the present disclosure may have optimized waist circumferential length and leg opening length.
    Type: Application
    Filed: January 27, 2017
    Publication date: May 18, 2017
    Inventors: Koichi Morimoto, Takashi Umeo, Hiroyuki Ueno, Katsuhiro Yonemura
  • Publication number: 20170077323
    Abstract: Disclosed is a method of manufacturing a solar cell module that comprises a step of obtaining a solar cell module that includes a translucent or transparent substrate including a substrate provided with translucency or transparency, and an antireflection film formed on a surface of the substrate provided with translucency or transparency, and a siloxane coat step of forming a siloxane layer on a surface of the antireflection film.
    Type: Application
    Filed: November 23, 2016
    Publication date: March 16, 2017
    Applicant: Panasonic Intellectual Property Management Co., Lt d.
    Inventors: Hirofumi YANO, Hiroyuki UENO, Ryoji NAITO, Toshio YAGIURA
  • Patent number: 9592163
    Abstract: Disposable pull-on diapers of the present disclosure may have optimized waist circumferential length and leg opening length.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: March 14, 2017
    Assignee: The Procter & Gamble Company
    Inventors: Koichi Morimoto, Takashi Umeo, Hiroyuki Ueno, Katsuhiro Yonemura
  • Patent number: D957543
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: July 12, 2022
    Assignee: MIKOTO CO. LTD.
    Inventor: Hiroyuki Ueno